US Patent Issued to The Regents of the University of California on May 26 for "Application of microbial glycosidase as an anti-viral therapeutic, prognostic, and diagnostic" (California Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,353, issued on May 26, was assigned to The Regents of the University of California (Oakland, Calif.).

"Application of microbial glycosidase as an anti-viral therapeutic, prognostic, and diagnostic" was invented by Cameron Martino (La Jolla, Calif.), Benjamin Kellman (La Jolla, Calif.), Nathan Lewis (La Jolla, Calif.), Robin Knight (La Jolla, Calif.), Jeffrey D. Esko (La Jolla, Calif.), Daniel Sandoval (La Jolla, Calif.) and Thomas Mandel Clausen (La Jolla, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions for diagnosing, preventing or treating a viral infection in a subject comprising administering to a subject in need th...